Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat

Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Hypertension plays a major role in the progression of both experimental and clinical chronic renal disease. However, the pathogenesis of the more slowly developing glomerulosclerosis that is seen e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2004-01, Vol.65 (1), p.209-218
Hauptverfasser:	Griffin, Karen A., Picken, Maria M., Bidani, Anil K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antihypertensive Agents - pharmacology Arterial hypertension. Arterial hypotension autoregulation Biological and medical sciences Blood and lymphatic vessels Blood Pressure - physiology Cardiology. Vascular system Clinical manifestations. Epidemiology. Investigative techniques. Etiology Drug Therapy, Combination Enalapril - pharmacology Glomerulosclerosis, Focal Segmental - physiopathology Hydralazine - pharmacology Hydrochlorothiazide - pharmacology hypertension Hypertension, Renal - drug therapy Hypertension, Renal - physiopathology Male Medical sciences Monitoring, Physiologic Nephrectomy Nephrology. Urinary tract diseases radiotelemetry Rats Rats, Sprague-Dawley remnant kidney Reserpine - pharmacology Telemetry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!